Diferencia entre revisiones de «HIV Prophylaxis (Non-Occupational)»
| Línea 13: | Línea 13: | ||
^Currently no PEP for Hep C | ^Currently no PEP for Hep C | ||
== | ==Treatment== | ||
===Negligible Risk=== | |||
#Urine, nasal secretions, saliva, sweat or tears not visibly contaminated with blood | |||
#HIV Post-Exposure Prophylaxis not recommended | |||
===Substantial Risk=== | |||
#Exposure of vagina, rectum, eye, mouth or other mucous membrane, non-intact skin, or percutaneous contact | |||
#With blood, semen, vaginal secretions, rectal secretions, breast milk, or any body fluid visibly contaminated with blood | |||
##<72 Hours | |||
###Source = Unknown HIV | |||
####-->Case-by-case determination | |||
###Source = Known HIV+ | |||
####-->28-day course of HAART | |||
#####(three-drug regimen), start ASAP | |||
##>72 Hours | |||
###-->No HAART recommended | |||
==Source== | ==Source== | ||
Revisión del 04:36 28 mar 2011
Workup
- Icon
- Consider Plan B
- Td
- Hepatitis B PEP for non-vaccinated
- Hepatitis B immunoglobulin and/or vaccine
- Labs
- Rapid HIV, hep pannel, RPR?
- Consider HIV PEP
- Basic labs, LFTs, if considering HIV PEP
- PD notification
^Currently no PEP for Hep C
Treatment
Negligible Risk
- Urine, nasal secretions, saliva, sweat or tears not visibly contaminated with blood
- HIV Post-Exposure Prophylaxis not recommended
Substantial Risk
- Exposure of vagina, rectum, eye, mouth or other mucous membrane, non-intact skin, or percutaneous contact
- With blood, semen, vaginal secretions, rectal secretions, breast milk, or any body fluid visibly contaminated with blood
- <72 Hours
- Source = Unknown HIV
- -->Case-by-case determination
- Source = Known HIV+
- -->28-day course of HAART
- (three-drug regimen), start ASAP
- -->28-day course of HAART
- Source = Unknown HIV
- >72 Hours
- -->No HAART recommended
- <72 Hours
Source
8/07 DONALDSON
